|
Canada-0-LaboratoriesTesting Azienda Directories
|
Azienda News:
- Nomifensine - Wikipedia
Nomifensine, formerly sold under the brand names Merital and Alival, is a norepinephrine–dopamine reuptake inhibitor (NDRI) drug [3] that was developed in the 1960s by Hoechst AG (now Sanofi-Aventis), [4] who then test marketed it in the United States
- Nomifensine: Uses, Interactions, Mechanism of Action | DrugBank
Nomifensine is now mainly used in scientific research, particularly in studies involving dopamine release in response to addiction
- Region and Domain Dependent Action of Nomifensine - PMC
So, the objectives of the present study were, first, to test the hypothesis that nomifensine exhibits domain-dependent actions in the NAcc and, second, to compare nomifensine’s actions in the NAcc with those in the DS (Taylor et al , 2013)
- Nomifensine - an overview | ScienceDirect Topics
Nomifensine is rapidly and completely absorbed after oral administration It has numerous metabolites, some of which are active It is 60-75% protein bound Nomifensine is 90% eliminated within the first 24 hours of a single dose
- Nomifensine ((±)-Nomifensine) | Norepinephrine Dopamine Reuptake . . .
Nomifensine ( (±)-Nomifensine) is a potent norepinephrine (NE) and dopamine (DA) reuptake inhibitor Nomifensine inhibits uptake of NE, DA and 5-HT in rat brain synaptosomes, with IC50 values of 6 6 nM, 48 nM and 830 nM, and Ki values of 4 7 nM, 26 nM and 4000 nM, respectively
- Nomifensine enantiomers: Psychopharmacological effects in mice and rats . . .
The D- and L-enantiomers of nomifensine (8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydrois-oquinoline) were tested for psychopharmacological effects in mice and rats with D,L-nomifensine hydrogen maleate as a reference drug
- What is Nomifensine? – Mental Health Matters
Nomifensine, sold under the brand names Merital and Alival, is a norepinephrine–dopamine reuptake inhibitor (NDRI), i e a drug that increases the amount of synaptic norepinephrine and dopamine available to receptors by blocking the dopamine and norepinephrine reuptake transporters
- Nomifensine | C16H18N2 | CID 4528 - PubChem
Nomifensine is an N -methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively It has a role as a dopamine uptake inhibitor Nomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia
- Nomifensine | 960 Publications | 25100 Citations | Top Authors . . .
Nomifensine is a research topic Over the lifetime, 949 publications have been published within this topic receiving 38040 citations The topic is also known as: R S-nomifensine D,L-nomifensine
- Nomifensine - Drug Targets, Indications, Patents - Synapse
The electrodes were implanted into the brains of rodent models to monitor the changes in neural and electrochemical signals across different brain regions during the administration of nomifensine
|
|